Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gitel

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
The feasibility of using concentrates containing factor IX for continuous infusionS Schulman, S Gitel, A Zivelin, et al.
Thrombosis and Haemostasis|March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand diseaseA Lubetsky, S Schulman, D Varon, et al.
Journal of Medical Virology|June 1, 1993
Response of hemophilic patients to poliovirus vaccination: correlation with HIV serology and with immunological parametersD Varon, R Handsher, R Dardik, et al.
Thrombosis and Haemostasis|September 1, 1993
Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factorR Dardik, Z M Ruggeri, N Savion, et al.
Stroke|June 3, 2000
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in childrenG Kenet, S Sadetzki, H Murad, et al.
The American Journal of Cardiology|December 1, 1998
Increased cardiovascular disease mortality rates in traumatic lower limb amputeesM Modan, E Peles, H Halkin, et al.
Thrombosis and Haemostasis|March 1, 1996
Feasibility of using recombinant factor VIIa in continuous infusionS Schulman, M Bech Jensen, D Varon, et al.
British Journal of Haematology|January 1, 1997
Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factorA Inbal, I Bank, A Zivelin, et al.
Pediatric Hematology and Oncology|October 1, 1993
Spectrum of clinical manifestations of antiphospholipid antibodies in childhood and adolescenceA Toren, P Toren, A Many, et al.
Blood|July 27, 1999
Extensive venous and arterial thrombosis associated with an inhibitor to activated protein CA Zivelin, S Gitel, J H Griffin, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
The feasibility of using concentrates containing factor IX for continuous infusionS Schulman, S Gitel, A Zivelin, et al.
Thrombosis and Haemostasis|March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand diseaseA Lubetsky, S Schulman, D Varon, et al.
Journal of Medical Virology|June 1, 1993
Response of hemophilic patients to poliovirus vaccination: correlation with HIV serology and with immunological parametersD Varon, R Handsher, R Dardik, et al.
Thrombosis and Haemostasis|September 1, 1993
Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factorR Dardik, Z M Ruggeri, N Savion, et al.
Stroke|June 3, 2000
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in childrenG Kenet, S Sadetzki, H Murad, et al.
The American Journal of Cardiology|December 1, 1998
Increased cardiovascular disease mortality rates in traumatic lower limb amputeesM Modan, E Peles, H Halkin, et al.
Thrombosis and Haemostasis|March 1, 1996
Feasibility of using recombinant factor VIIa in continuous infusionS Schulman, M Bech Jensen, D Varon, et al.
British Journal of Haematology|January 1, 1997
Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factorA Inbal, I Bank, A Zivelin, et al.
Pediatric Hematology and Oncology|October 1, 1993
Spectrum of clinical manifestations of antiphospholipid antibodies in childhood and adolescenceA Toren, P Toren, A Many, et al.
Blood|July 27, 1999
Extensive venous and arterial thrombosis associated with an inhibitor to activated protein CA Zivelin, S Gitel, J H Griffin, et al.
Pageof 3